4D Molecular TherapeuticsFDMT
那斯達克 · USD
13.49
-0.69
(-4.87%)
收盤 09/11 03:59 (UTC+8)
盤後
13.55
+0.06
(+0.44%)
09/11 03:59 (UTC+8)
4D Molecular TherapeuticsFDMT
13.49
-0.69
(-4.87%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.85
- 0.03
- 0.04
- -
- -82.14
- -40.00
- -66.67
- 1300.00
- 7.14
- 500.00
- 94444.44
- -96.42
- 24.09
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 3,781 | 3,047 | 85,090 | 90 | 15 | 14 | 1 | 3 | 5 | 28 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 3,781 | 3,047 | 85,090 | 90 | 15 | 14 | 1 | 3 | 5 | 28 |
營業費用 | 80,807 | 76,667 | 70,375 | 61,275 | 59,471 | - | 56,118 | - | - | - |
研發費用 | 68,282 | 64,980 | 57,608 | 49,438 | 47,951 | 40,699 | 43,087 | 38,485 | 31,857 | 27,870 |
推銷及管理費用 | 12,525 | 11,687 | 12,767 | 11,837 | 11,520 | 12,936 | 13,031 | 12,650 | 10,604 | 10,294 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -77,026 | -73,620 | 14,715 | -61,185 | -59,456 | -53,621 | -56,117 | -51,132 | -42,456 | -38,136 |
其他收入及費用 | 4,090 | 4,860 | 4,682 | 4,309 | 4,798 | 5,649 | 6,446 | 7,289 | 7,503 | 5,735 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -72,936 | -68,760 | 19,397 | -56,876 | -54,658 | -47,972 | -49,671 | -43,843 | -34,953 | -32,401 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -72,936 | -68,760 | 19,397 | -56,876 | -54,658 | -47,972 | -49,671 | -43,843 | -34,953 | -32,401 |
基本每股稅後盈餘(元) | -1.04 | -1.01 | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 |
稀釋每股稅後盈餘(元) | -1.04 | -1.01 | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 |
基本平均股數(千股) | 70272.00 | 68064.00 | 63923.00 | 56126.00 | 55927.00 | 55744.00 | 55667.00 | 55554.00 | 55282.00 | 49271.00 |
稀釋平均股數(千股) | 70272.00 | 68064.00 | 63923.00 | 56126.00 | 55927.00 | 55744.00 | 55667.00 | 55554.00 | 55282.00 | 49271.00 |
還原基本每股稅後盈餘(元) | -1.04 | -1.01 | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 |
還原稀釋每股稅後盈餘(元) | -1.04 | -1.01 | 0.43 | -1.01 | -0.98 | -0.86 | -0.90 | -0.79 | -0.63 | -0.66 |
還原基本平均股數(千股) | 70,272 | 68,064 | 63,923 | 56,126 | 55,927 | 55,744 | 55,667 | 55,554 | 55,282 | 49,271 |
還原稀釋平均股數(千股) | 70,272 | 68,064 | 63,923 | 56,126 | 55,927 | 55,744 | 55,667 | 55,554 | 55,282 | 49,271 |
EBITDA(千元) | -71,837 | -67,839 | 20,230 | -56,027 | -53,936 | -47,485 | -49,737 | -44,380 | -35,664 | -31,564 |